Fund shareholders of SANGAMO THERAPEUTICS INC
ISIN US8006771062 · United States · LEI 2549006WMRKRC4G32Z67
- Fund shareholders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 33.4K $
- Share of capital
- 0.1 % of 414.3M shares on Mar 25, 2026
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 400,000 | 21.6K $ | 0.00 % | 0.10 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 220,038 | 11.9K $ | 0.00 % | 0.05 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | -28 | 620,038 | -97.0 % |
| 2026Q2 | 30 | +2 | 20,664,149 | +32.0 % |
| 2026Q1 | 28 | -3 | 15,650,533 | -0.1 % |
| 2025Q4 | 31 | -3 | 15,664,327 | -26.1 % |
| 2025Q3 | 34 | -5 | 21,190,237 | +2.9 % |
| 2025Q2 | 39 | -5 | 20,598,755 | -27.7 % |
| 2025Q1 | 44 | +6 | 28,484,051 | -10.2 % |
| 2024Q4 | 38 | -58 | 31,725,497 | -25.6 % |
| 2024Q3 | 96 | -25 | 42,666,560 | -6.2 % |
| 2024Q2 | 121 | -1 | 45,473,717 | +20.6 % |
| 2024Q1 | 122 | -16 | 37,719,412 | -15.1 % |
| 2023Q4 | 138 | 44,424,244 |
Institutional managers
107 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 40,400,067 | 10M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 6,270,441 | 1.5M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 5,288,097 | 1.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,570,862 | 1.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,547,848 | 1.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 3,836,665 | 947.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,570,992 | 635K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,352,360 | 580.8K $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,050,384 | 506.2K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,838,390 | 452.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,694,783 | 418.4K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,687,463 | 416.6K $ | as of Mar 31, 2026 |
| LUMINUS MANAGEMENT LLC | 1,681,089 | 415.1K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,218,671 | 300.9K $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,045,232 | 258.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 737,867 | 182.2K $ | as of Mar 31, 2026 |
| HighTower Advisors, LLC | 706,481 | 174.4K $ | as of Mar 31, 2026 |
| SANDERS MORRIS HARRIS LLC | 668,000 | 164.9K $ | as of Mar 31, 2026 |
| MAK CAPITAL ONE LLC | 561,538 | 138.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 423,265 | 104.5K $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 400,000 | 99K $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 397,100 | 98K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 377,287 | 93.2K $ | as of Mar 31, 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 361,277 | 89.2K $ | as of Mar 31, 2026 |
| Diametric Capital, LP | 353,477 | 87.3K $ | as of Mar 31, 2026 |
Declared shareholders of SANGAMO THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.38 % | 38,860,819 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of SANGAMO THERAPEUTICS INC". https://titelia.com/en/stocks/sangamo-therapeutics-inc-US8006771062